Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity
- PMID: 2137269
- DOI: 10.1097/00007890-199001000-00031
Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity
Abstract
In models of tolerance associated with mixed lymphoid chimerism, depletion of Thy 1+ cells from the allogeneic donor inoculum may decrease the level of chimerism achieved and the capacity of donor cells to induce tolerance. To determine whether the apparent role of Thy 1+ cells in the facilitation of bone marrow engraftment and induction of skin graft tolerance is related to alloaggression, the capacity of fully allogeneic C57BL/6J, H-2b BM cells to establish mixed lymphoid chimerism and skin graft tolerance in sublethally irradiated (2.5 Gy x 3) BALB/c, H-2d hosts was compared with that of semi-allogeneic BALB/c x C57BL/6J F1 H-2d/b BM cells which genetically lack the potential for graft-versus-host reactivity against parental recipients. The levels of mixed chimerism observed with allogeneic and semi-allogeneic F1 BM cells were nearly identical: 21.0 +/- 9.7% of spleen cells in H-2b BM-injected and 18.6 +/- 8.8% of spleen cells in H-2d/b BM-injected H-2d hosts were of donor allotype. There was no difference in the fraction of hosts rendered tolerant to C57BL/6J, H-2b skin grafts by H-2b vs. H-2d/b BM at either excess (94% vs. 92% tolerant) or threshold (37% vs. 40% tolerant) numbers of donor cells. Spleen cells from both types of mixed chimeras failed to respond to donor antigens in MLR. Both H-2b and H-2d/b BM-injected H-2d hosts rejected third party C3H/HeJ, H-2k skin grafts and responded to third party stimulators in MLR. Although these nonspecific allo-immune responses were not as strong as the responses of normal animals, they were suppressed to an equivalent degree in both types of chimeras. Graft-versus-host disease, if present in irradiated H-2b BM-injected hosts, did not significantly affect survival compared with survival of irradiated H-2d/b BM-injected animals. These results suggest that the tolerizing capacity of allogeneic BM does not depend upon GVHD and that allogeneic and semi-allogeneic BM establish mixed lymphoid chimerism and induce skin graft tolerance by similar mechanisms across a complete MHC disparity in sublethally irradiated adult hosts.
Similar articles
-
Effects of Thy-1+ cell depletion on the capacity of donor lymphoid cells to induce tolerance across an entire MHC disparity in sublethally irradiated adult hosts.Transplantation. 1989 Aug;48(2):289-96. doi: 10.1097/00007890-198908000-00021. Transplantation. 1989. PMID: 2569241
-
Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.Transplantation. 1999 Nov 27;68(10):1560-7. doi: 10.1097/00007890-199911270-00021. Transplantation. 1999. PMID: 10589955
-
Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.Transplantation. 1991 Jun;51(6):1262-7. doi: 10.1097/00007890-199106000-00022. Transplantation. 1991. PMID: 1828637
-
Influence of graft versus host reaction on the T cell repertoire differentiating from bone marrow precursors following allogeneic bone marrow transplantation.Transpl Immunol. 1997 Jun;5(2):75-82. doi: 10.1016/s0966-3274(97)80046-9. Transpl Immunol. 1997. PMID: 9269028 Review.
-
Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.World J Surg. 2000 Jul;24(7):797-810. doi: 10.1007/s002680010128. World J Surg. 2000. PMID: 10833246 Review.
Cited by
-
Transplantation of hematopoietic stem cells for induction of unresponsiveness to organ allografts.Springer Semin Immunopathol. 2004 Nov;26(1-2):169-85. doi: 10.1007/s00281-004-0171-5. Epub 2004 Sep 11. Springer Semin Immunopathol. 2004. PMID: 15368079 Review.
-
Immune tolerance in recipients of combined haploidentical bone marrow and kidney transplantation.Bone Marrow Transplant. 2015 Jun;50 Suppl 2(Suppl 2):S82-6. doi: 10.1038/bmt.2015.102. Bone Marrow Transplant. 2015. PMID: 26039215 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials